Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia. Fruchtman H, Avigan ZM, Waksal JA, Brennan N, et al. Leukemia 2024 Apr 10. doi: 10.1038/s41375-024-02246.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fruchtman H, Avigan ZM, Waksal JA, Brennan N, et al. Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia. Leukemia 2024 Apr 10. doi: 10.1038/s41375-024-02246.
PMID: 38600315